Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study

By Platteau Peter   Andersen Anders Nyboe   Balen Adam   Devroey Paul   Sørensen Per   Helmgaard Lisbeth   for the Menopur Ovulation Induction (MOI) Study Group  

Human Reproduction, Vol. 21, Iss. 7, 2006-07 ,pp. : 1798-1804

Oxford University Press

Access to resources Recommend Favorite

Impact of highly purified urinary FSH and recombinant FSH on haemostasis: an open‐label, randomized, controlled trial

By Ricci G.   Cerneca F.   Simeone R.   Pozzobon C.   Guarnieri S.   Sartore A.   Pregazzi R.   Guaschino S.  

Human Reproduction, Vol. 19, Iss. 4, 2004-04 ,pp. : 838-848

Oxford University Press

Access to resources Recommend Favorite

Combined metformin and clomiphene citrate versus highly purified FSH for ovulation induction in clomiphene-resistant PCOS women: a randomised controlled trial

By Abu Hashim Hatem   Wafa Alaa   El Rakhawy Mohamed  

Gynecological Endocrinology, Vol. 27, Iss. 3, 2011-03 ,pp. : 190-196

Informa Healthcare

Access to resources Recommend Favorite

Endocrinology. Induction of ovulation in women undergoing assisted reproductive techniques: recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP)

By Lenton E.  

Human Reproduction, Vol. 15, Iss. 5, 2000-05 ,pp. : 1021-1027

Oxford University Press

Access to resources Recommend Favorite

Predicting the FSH threshold dose in women with WHO Group II anovulatory infertility failing to ovulate or conceive on clomiphene citrate

By Nyboe Andersen Anders   Balen Adam   Platteau Peter   Devroey Paul   Helmgaard Lisbeth   Arce Joan-Carles  

Human Reproduction, Vol. 23, Iss. 6, 2008-06 ,pp. : 1424-1430

Oxford University Press

Access to resources Recommend Favorite